Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Innovation Bill Scorecard: Device, Diagnostic Provisions In Senate And House

This article was originally published in The Gray Sheet

Executive Summary

On April 6, the Senate HELP Committee finished the last of three markup sessions on medical innovation bills designed to be the Senate's version of the 21st Century Cures Act, which passed the House last July. Check out this Gray Sheet chart that lists device-relevant bills that have passed through the HELP Committee aligned with similar House Cures' provisions.


Related Content

House Set To Vote On Cures Nov. 30; Latest Version Includes 510(k)s In Breakthrough Pathway
Congress Likely To Vote On Cures Bill Package After Thanksgiving
Medical Innovation Bills On Fast Track In Congress, But Some Barriers Remain
US FDA Agrees To CLIA Waiver Process Reforms, But More Is Needed, Coalition Says
Quest For Political Capital, Legacy Could Push 'Cures' Over The Finish Line
Senate Moves To Floor Phase For Innovation Bill; Postmarket Surveillance, LDTs Could Get Attention





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts